openPR Logo
Press release

Non-pharmacy market of OTC products in Poland: up by 4% in 2011-2013

09-19-2011 09:23 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: PMR Ltd

Non-pharmacy market of OTC products in Poland: up by 4%

According to the latest report published by the research and consulting company PMR, entitled “Non-pharmacy OTC market in Poland 2011. Development forecasts for 2011-2013”, the value of the non-pharmacy market of OTC medicines and dietary supplements in Poland stood at approx. PLN 1bn (€250m) in 2010 and increased very little from the 2009 level. The market is poised to grow 4-5% in 2011-2013.

Weaker year for non-pharmacy market
According to PMR estimates, in 2009 the non-pharmacy market of OTC products in Poland (comprising medicines and dietary supplements) rose by around 11% year on year and exceeded PLN 1bn (€250m) for the first time on record. The year 2010 was a period of poorer growth for the pharmaceutical market as a whole, as reflected by developments in the non-pharmacy market which expanded by approx. 1%. Some of the reasons behind the poorer growth included a high base of comparison from the previous year and the entry into force of a new list of products admitted to trading in general stores in October 2009. The list did not bring in any revolutionary changes as the modifications mostly concerned the inclusion in the list of new package sizes and dosages of popular medicines. However, these changes only added to the diversification of brands available in non-pharmacy channels, but they did not boost the market’s value.
PMR expects that 2011 will be a better year in terms of sales of OTC products when compared to 2010. “According to our forecasts, the non-pharmacy market of OTC products will grow by around 5% in 2011. Growth rate in 2012 and 2013 is expected to be approx. 4% annually” says Agnieszka Skonieczna, PMR Senior Pharmaceutical Market Analyst and the report co-author.

Share of non-pharmacy sales declines
According to PMR estimates, in 2010 non-pharmacy sales accounted for around 12% of the OTC market in Poland. As a result of legal changes restricting the number of products admitted to non-pharmacy trading (the October 2009 list, the Act on Food and Nutrition Safety), the share of non-pharmacy sales dropped as compared to the previous years. In 2008, it stood at 14%.

In-store display as the key aspect boosting non-pharmacy sales
Rules for in-store display of OTC products are similar to those applied for other products sold in hypermarkets. The display of products on free-standing shelving units is crucial; the most attractive shelves are those at waist to eye level (more or less from 120 cm to 160 cm). “If sales attributed to products at the eye-level are defined as 100%, then above the head, they fall to 60%, and between waist and eye level to 50%, and at the level of leaning down – i.e. the first shelf – as low as 20% of the sales from the eye-level shelves” says Monika Stefańczyk, PMR Head Pharmaceutical Market Analyst and the report co-author. In addition, shoppers are more inclined to reach for products situated on their right.
According to the store check carried out by PMR for the purposes of the report, OTC products are usually displayed in three spots in hypermarket-type stores:
- on “a healthcare shelf”, i.e. a separate shelf dedicated to the display of healthcare products
- on shelves with teas (herbal and functional teas)
- in the checkout area.
Besides, the researched products are infrequently displayed on separate stands or promotional shelves to the side of a shelving unit.
On average, a typical hypermarket in Poland sells 109 products with the status of a medicine, dietary supplement or herb.

This press release is based on information contained in the latest PMR report entitled “Non-pharmacy OTC market in Poland 2011. Development forecasts for 2011-2013” http://www.pmrpublications.com/online_shop/Non-pharmacy-OTC-market-Poland-2011.shtml.

For more information on the report please contact:
Marketing Department:
tel. /48/ 12 618 90 00
e-mail: marketing@pmrcorporate.com

PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.

Dekerta 24
30-703 Kraków

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-pharmacy market of OTC products in Poland: up by 4% in 2011-2013 here

News-ID: 192342 • Views: 1534

More Releases from PMR Ltd

60% of Polish SMEs use IT services
Approx. 60% of small and medium sized enterprises use IT services in Poland. Some 30% of SMEs declare to employ people responsible for IT. The number of portable computers used by SMEs has been growing. On average, there are five such computers per one SME. The proportion of companies which use EU funds to finance ICT development has gone down over the last two years. Use of IT services According to the
Ukrainian IT industry to keep on growing in 2012-2013
In the last two years Ukrainian IT market has been recovering after a sharp decline experienced in 2009. The market will continue to record double digit growth rates in 2012-2013. The macroeconomic and political situation will remain of crucial importance in the country. Current situation and key trends According to the latest report “IT market in Ukraine 2012. Development forecasts for 2012-2017” published by PMR, a market research company, the total
Retail grocery market to provide €117bn in 2014 in the CE region
PMR estimates that in 2011 the grocery market in six Central European (CE) countries was worth nearly €107bn, 2.8% more than the previous year when expressed in local currencies. The increase was generated foremost by the discount stores and supermarket segments, and was driven by the skyrocketing prices of foodstuffs. Schwarz Group, which operates the Lidl and Kaufland chains, is a leading grocery player in the CE region – as
Hungarian construction market to recover in 2013-2014
After a poor 2009-2012 for the Hungarian construction industry, from 2013 a visible market recovery is expected. The growth in 2013-2014 will result from the intense execution of EU co-financed infrastructure investments as well as some revival in building construction, particularly in non-residential buildings. According to the research company PMR’s latest report, entitled “Construction sector in Hungary 2012 – Development forecasts for 2012-2014”, weak macroeconomic environment, falling investment demand and poor

All 5 Releases


More Releases for OTC

Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
Foods Matrix Inc. Exploring OTC Markets Listing
Foods Matrix Inc. (FMI), a US based food processing startup is exploring options to list on the OTC Markets. FMI is in talks to acquire a distressed food processing unit in the state of Punjab, India for US $3 million. The deal may be sealed by the end of November, 2018, post completion of the ongoing due diligence. FMI may initially quote on the pink sheet segment of the OTC Markets
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
11-28-2017 | Health & Medicine
Fact.MR
7 Key Projections for OTC Analgesics Market
The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Request For Sample Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years. Various off-label drugs including tricyclic antidepressants, antihistamines,
OTC Drug Market Report Research : 2017
Reports And Markets Publish a New Market Research Report On –" OTC Drug Market Report Research : 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/asia-pacific-otc-drug-market-report-2017-1541262 In this report, the Asia-Pacific OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several